{"id":"https://openalex.org/W129198718","doi":null,"title":"Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.","display_name":"Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W129198718","mag":"129198718","pmid":"https://pubmed.ncbi.nlm.nih.gov/11702959"},"language":"en","primary_location":{"id":"pmid:11702959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11702959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039034056","display_name":"Vincent J. Picozzi","orcid":"https://orcid.org/0009-0002-3493-7769","observed_orcids":["https://orcid.org/0009-0002-3493-7769","https://orcid.org/0009-0004-4604-9229"]},"institutions":[{"id":"https://openalex.org/I1317886745","display_name":"Virginia Mason Medical Center","ror":"https://ror.org/00cm2cb35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1317886745","https://openalex.org/I2802797007","https://openalex.org/I4210118434"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V J Picozzi","raw_affiliation_strings":["Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington 98111, USA. hemvjp@vmmc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington 98111, USA. hemvjp@vmmc.org","institution_ids":["https://openalex.org/I1317886745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013767912","display_name":"Brad L. Pohlman","orcid":"https://orcid.org/0000-0001-6006-3714","observed_orcids":["https://orcid.org/0000-0001-6006-3714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B L Pohlman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111636012","display_name":"V. A. Morrison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V A Morrison","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009875185","display_name":"Grant D. Lawless","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G D Lawless","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100359261","display_name":"Minwoo Lee","orcid":"https://orcid.org/0000-0001-8474-5744","observed_orcids":["https://orcid.org/0000-0001-8474-5744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M W Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034887576","display_name":"Robert O. Kerr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R O Kerr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014972879","display_name":"J. Ford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Ford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103869421","display_name":"David J. Delgado","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J Delgado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112781093","display_name":"Moshe Fridman","orcid":"https://orcid.org/0000-0002-0406-1260","observed_orcids":["https://orcid.org/0000-0002-0406-1260"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Fridman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009741336","display_name":"W.Bradford Carter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W B Carter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7441,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.69540321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"15","issue":"10","first_page":"1296","last_page":"306; discussion 1310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.8740000128746033},{"id":"https://openalex.org/keywords/treatment-omission","display_name":"treatment omission","score":0.3569999933242798},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9190000295639038},{"id":"https://openalex.org/keywords/growth-factor-prophylaxis","display_name":"growth factor prophylaxis","score":0.921999990940094},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.9369999766349792},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.4970000088214874},{"id":"https://openalex.org/keywords/cardiovascular-comorbidity","display_name":"cardiovascular comorbidity","score":0.9409999847412109},{"id":"https://openalex.org/keywords/variation-in-clinical-practice","display_name":"clinical practice variation","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8884458541870117},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.661125123500824},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6268066167831421},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6146242022514343},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5975260138511658},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5073215365409851},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.5059697031974792},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.49938082695007324},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.4974360764026642},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.49721840023994446},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.47342947125434875},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4665251672267914},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4581221342086792},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40369290113449097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3797988295555115}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006133","descriptor_name":"Growth Substances","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11702959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11702959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Comparative Study"},{"id":"mag:129198718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11702959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1524381114","https://openalex.org/W1811037815","https://openalex.org/W1868843221","https://openalex.org/W1902422509","https://openalex.org/W1905145727","https://openalex.org/W1924320258","https://openalex.org/W1933587402","https://openalex.org/W1966140433","https://openalex.org/W2000445173","https://openalex.org/W2065910438","https://openalex.org/W2087824134","https://openalex.org/W2114046957","https://openalex.org/W2123874586","https://openalex.org/W2154011558","https://openalex.org/W2168558729","https://openalex.org/W2248478085","https://openalex.org/W2318772898","https://openalex.org/W2341557816","https://openalex.org/W3022798003"],"related_works":["https://openalex.org/W150781056","https://openalex.org/W1990829116","https://openalex.org/W2026675506","https://openalex.org/W2980240158","https://openalex.org/W2152807596","https://openalex.org/W1981648240","https://openalex.org/W2580034065","https://openalex.org/W2597137249","https://openalex.org/W2087227905","https://openalex.org/W2462063282"],"abstract_inverted_index":{"Records":[0],"from":[1,45,237],"653":[2,33,114],"patients":[3,25,49,96,115,155,191,230],"treated":[4],"between":[5],"1991":[6],"and":[7,136,177,193],"1998":[8],"in":[9,24,168,204,212],"the":[10,32,81,142,153,205],"Oncology":[11],"Practice":[12],"Patterns":[13],"Study":[14],"(OPPS)":[15],"were":[16,180],"analyzed":[17],"to":[18,86,103,122,140,189,229],"determine":[19],"contemporary":[20],"chemotherapy":[21,119,127,150,169,227,245],"delivery":[22,228,246],"patterns":[23],"with":[26,97,200,231],"intermediate-grade":[27,232],"non-Hodgkin's":[28],"lymphoma":[29],"(NHL).":[30],"Of":[31,93],"patient":[34,214],"records":[35],"reviewed,":[36],"90":[37],"(14%)":[38],"omitted":[39],"an":[40,71,87],"anthracycline":[41],"or":[42,60,90,126,132,159,166],"mitoxantrone":[43],"(Novantrone)":[44],"primary":[46,195],"therapy.":[47],"Among":[48,152],"receiving":[50,216],"CHOP":[51,158],"(cyclophosphamide":[52],"[Cytoxan,":[53],"Neosar],":[54],"doxorubicin":[55],"HCl,":[56],"vincristine":[57],"[Oncovin],":[58],"prednisone)":[59],"CNOP":[61],"(cyclophosphamide,":[62],"mitoxantrone,":[63],"vincristine,":[64],"prednisone),":[65],"134":[66],"(27%)":[67],"of":[68,76,80,113,124,207,226,242],"492":[69,154],"received":[70,117,157],"average":[72],"relative":[73],"dose":[74,170,219],"intensity":[75,220],"less":[77],"than":[78],"80%":[79],"literature-referenced":[82],"dose,":[83],"due":[84,120],"either":[85,121],"inadequate":[88],"planned":[89],"delivered":[91],"dose.":[92],"181":[94],"advanced-stage":[95],"responsive":[98],"disease,":[99],"28":[100],"(15%)":[101],"failed":[102],"receive":[104],"at":[105],"least":[106],"six":[107],"treatment":[108],"cycles.":[109],"Overall,":[110],"283":[111],"(43%)":[112],"potentially":[116],"suboptimal":[118],"choice":[123],"regimen":[125],"delivered.":[128],"Patient":[129],"age":[130],">":[131],"=":[133,222],"65":[134],"years":[135],"cardiac":[137],"comorbidity":[138],"appeared":[139],"have":[141],"greatest":[143],"influence":[144],"on":[145],"a":[146,164,201],"physician's":[147],"decision":[148],"regarding":[149],"administration.":[151],"who":[156],"CNOP,":[160],"235":[161],"(48%)":[162],"experienced":[163],"delay":[165],"reduction":[167,203],"(usually":[171],"neutropenia-related),":[172],"100":[173],"(20%)":[174],"developed":[175],"mucositis,":[176],"116":[178],"(24%)":[179],"hospitalized":[181],"for":[182,209],"febrile":[183,210],"neutropenia.":[184],"Growth":[185],"factor":[186],"was":[187,198],"administered":[188],"261":[190],"(53%),":[192],"its":[194],"prophylactic":[196],"use":[197],"associated":[199],"significant":[202,235],"incidence":[206],"hospitalizations":[208],"neutropenia":[211],"all":[213],"subgroups":[215],"appropriate":[217],"chemotherapeutic":[218],"(P":[221],".02).":[223],"This":[224],"assessment":[225],"NHL":[233],"showed":[234],"variation":[236],"current":[238],"standards.":[239],"Further":[240],"analysis":[241],"factors":[243],"influencing":[244],"might":[247],"improve":[248],"therapeutic":[249],"outcomes.":[250]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}